You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

CLINICAL TRIALS PROFILE FOR CARIPRAZINE HYDROCHLORIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CARIPRAZINE HYDROCHLORIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00488618 ↗	Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania	Completed	Gedeon Richter Ltd.	Phase 2	2007-06-01	This is a study designed to evaluate the efficacy, safety, and tolerability of RGH-188 monotherapy in the treatment of acute mania. This study will be 5 weeks in duration; 3 weeks double-blind treatment and 2-weeks safety follow-up. All patients meeting the eligibility criteria will be randomized to one of two treatment groups: RGH-188 or placebo
NCT00488618 ↗	Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania	Completed	Forest Laboratories	Phase 2	2007-06-01	This is a study designed to evaluate the efficacy, safety, and tolerability of RGH-188 monotherapy in the treatment of acute mania. This study will be 5 weeks in duration; 3 weeks double-blind treatment and 2-weeks safety follow-up. All patients meeting the eligibility criteria will be randomized to one of two treatment groups: RGH-188 or placebo
NCT00694707 ↗	Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia	Completed	Gedeon Richter Ltd.	Phase 2	2008-06-30	This is a study to evaluate the safety, efficacy, and tolerability of cariprazine (RGH-188) relative to placebo in adult patients (18-60 years of age) with acute exacerbation of schizophrenia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CARIPRAZINE HYDROCHLORIDE

Condition Name

Chart
Table

Condition Name for CARIPRAZINE HYDROCHLORIDE
Intervention	Trials
Schizophrenia	13
Major Depressive Disorder	7
Bipolar I Disorder	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CARIPRAZINE HYDROCHLORIDE
Intervention	Trials
Disease	18
Schizophrenia	13
Depressive Disorder	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CARIPRAZINE HYDROCHLORIDE

Trials by Country

Map
Table

Trials by Country for CARIPRAZINE HYDROCHLORIDE
Location	Trials
United States	468
Ukraine	44
India	35
Japan	20
Romania	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CARIPRAZINE HYDROCHLORIDE
Location	Trials
California	30
Texas	29
Ohio	28
Florida	26
New York	23
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CARIPRAZINE HYDROCHLORIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CARIPRAZINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	23
Phase 2	12
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CARIPRAZINE HYDROCHLORIDE
Clinical Trial Phase	Trials
Completed	23
Not yet recruiting	6
Recruiting	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CARIPRAZINE HYDROCHLORIDE

Sponsor Name

Chart
Table

Sponsor Name for CARIPRAZINE HYDROCHLORIDE
Sponsor	Trials
Forest Laboratories	22
Gedeon Richter Ltd.	17
Allergan	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CARIPRAZINE HYDROCHLORIDE
Sponsor	Trials
Industry	55
Other	8
NIH	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.